Veru Inc (VERU)
1.32
-0.05
(-3.65%)
USD |
NASDAQ |
May 17, 16:00
1.35
+0.03
(+2.27%)
After-Hours: 20:00
Veru Price: 1.32 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 1.39 | 1.39 | 1.25 | 1.32 | 1.568M |
| May 16, 2024 | 1.45 | 1.485 | 1.35 | 1.37 | 1.023M |
| May 15, 2024 | 1.51 | 1.52 | 1.42 | 1.47 | 1.426M |
| May 14, 2024 | 1.42 | 1.57 | 1.38 | 1.47 | 2.680M |
| May 13, 2024 | 1.32 | 1.39 | 1.305 | 1.33 | 1.084M |
| May 10, 2024 | 1.38 | 1.45 | 1.33 | 1.33 | 1.386M |
| May 09, 2024 | 1.45 | 1.48 | 1.30 | 1.37 | 2.050M |
| May 08, 2024 | 1.41 | 1.640 | 1.30 | 1.43 | 3.313M |
| May 07, 2024 | 1.63 | 1.70 | 1.60 | 1.63 | 2.098M |
| May 06, 2024 | 1.63 | 1.75 | 1.555 | 1.64 | 1.983M |
| May 03, 2024 | 1.66 | 1.71 | 1.550 | 1.63 | 2.920M |
| May 02, 2024 | 1.47 | 1.72 | 1.440 | 1.64 | 4.124M |
| May 01, 2024 | 1.38 | 1.49 | 1.35 | 1.49 | 3.251M |
| Apr 30, 2024 | 1.26 | 1.42 | 1.26 | 1.35 | 3.713M |
| Apr 29, 2024 | 1.26 | 1.32 | 1.17 | 1.25 | 2.334M |
| Apr 26, 2024 | 1.24 | 1.28 | 1.21 | 1.27 | 1.282M |
| Apr 25, 2024 | 1.31 | 1.347 | 1.21 | 1.21 | 2.063M |
| Apr 24, 2024 | 1.30 | 1.38 | 1.28 | 1.32 | 1.553M |
| Apr 23, 2024 | 1.29 | 1.48 | 1.27 | 1.275 | 2.636M |
| Apr 22, 2024 | 1.35 | 1.355 | 1.25 | 1.27 | 1.410M |
| Apr 19, 2024 | 1.39 | 1.55 | 1.30 | 1.31 | 2.614M |
| Apr 18, 2024 | 1.14 | 1.425 | 1.00 | 1.42 | 7.020M |
| Apr 17, 2024 | 1.25 | 1.28 | 1.125 | 1.16 | 2.515M |
| Apr 16, 2024 | 1.42 | 1.44 | 1.24 | 1.255 | 3.203M |
| Apr 15, 2024 | 1.51 | 1.53 | 1.11 | 1.53 | 7.168M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.37
Minimum
Jan 19 2024
23.78
Maximum
Aug 17 2022
5.230
Average
3.46
Median
Jan 02 2020
Price Benchmarks
| EyePoint Pharmaceuticals Inc | 11.84 |
| INVO Bioscience Inc | 0.985 |
| Bio-Path Holdings Inc | 2.14 |
| Aileron Therapeutics Inc | 3.79 |
| ProKidney Corp | 4.055 |
Price Related Metrics
| PS Ratio | 10.42 |
| Price to Book Value | 4.274 |
| Earnings Yield | -25.76% |
| Market Cap | 193.23M |